Skip Navigation
Skip to contents

CPP : Cardiovascular Prevention and Pharmacotherapy

Sumissioin : submit your manuscript
SEARCH
Search

Author index

Page Path
HOME > Browse articles > Author index
Search
Dae-Jeong Koo 1 Article
The crosstalk between insulin resistance and nonalcoholic fatty liver disease/metabolic dysfunction-associated fatty liver disease: a culprit or a consequence?
Dae-Jeong Koo, Won-Young Lee
Cardiovasc Prev Pharmacother. 2022;4(4):132-141.   Published online October 20, 2022
DOI: https://doi.org/10.36011/cpp.2022.4.e17
  • 21,521 View
  • 194 Download
  • 9 Citations
Abstract PDF
Nonalcoholic fatty liver disease (NAFLD), which has recently undergone a change in its definition and acronym to “metabolic dysfunction associated fatty liver disease (MAFLD),” is clinically significant as an increasingly prevalent independent risk factor for cardiovascular diseases. Insulin resistance is considered to be a key mechanism in the development and progression of NAFLD/MAFLD, and fatty liver disease itself may exacerbate insulin resistance. In this review, we describe the mechanisms underlying the interaction between insulin resistance and fatty liver, and we summarize the therapeutic attempts based on those mechanisms.

Citations

Citations to this article as recorded by  
  • Effects of carbohydrate-modified diets on insulin sensitivity in children and adolescents with overweight/obesity: a systematic review and meta-analysis of randomized controlled trials
    Yasaman Khorshidi, Nazanin Moslehi, Faraneh Zolfaghari, Mahdieh Golzarand, Golaleh Asghari
    BMC Endocrine Disorders.2026;[Epub]     CrossRef
  • Thermoacoustic Ultrasound Assessment of Liver Steatosis—A Novel Approach for MASLD Diagnosis
    Jang Hwan Cho, Christopher M. Bull, Michael Thornton, Jing Gao, Jonathan M. Rubin, Idan Steinberg
    Diagnostics.2026; 16(5): 804.     CrossRef
  • Beyond the Liver: Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Associated 35% Higher Risk of Clinically Diagnosed Heart Failure With Preserved Ejection Fraction (HFpEF)
    Mona A. Hegazy, Saeed Soliman, Marwa Mostafa Ahmed, Abeer Attia, Syrine Bellakhal, Nadia Mostafa Tawfik, Amin R. Soliman
    Current Cardiology Reports.2026;[Epub]     CrossRef
  • Prevalence of Triglyceride–Glucose Index-Defined Insulin Resistance and Its Association with Recorded Cardiovascular Disease Among Adults in the Municipality of Naples: A Cross-Sectional Primary-Care Study
    Serafino Fazio, Vincenzo Santagada, Gaetano Piccinocchi, Giuseppe Signoriello, Rosanna Ortolani, Ilaria Loperto, Flora Affuso, Roberto Piccinocchi, Ilenia Lorenza Calcaterra, Matteo Di Minno
    Journal of Clinical Medicine.2026; 15(21): 8244.     CrossRef
  • Nonalcoholic fatty liver disease and heart failure with preserved ejection fraction: a focus on risk factors and management
    Joonpyo Lee, Mi-Seung Shin
    Cardiovascular Prevention and Pharmacotherapy.2025; 7(1): 1.     CrossRef
  • Interplay of the pathophysiological mechanisms of non-alcoholic fatty liver disease, diabetes mellitus, and inflammation: A growing threat to public health
    Sharon Olabisoye Oladipupo, Emmanuel Henry Ezenabor, Adebola Busola Ojo, Akingbolabo Daniel Ogunlakin, Oluwafemi Adeleke Ojo
    Obesity Medicine.2025; 55: 100613.     CrossRef
  • Association of Apolipoprotein C-III Gene Polymorphisms (rs2854116 and rs2854117) with Susceptibility to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Turkish Population
    Damla Karaagac, Suat Morkuzu, Naci Senkal, Ersel Bilgin, Yasemin Oyacı, Tufan Tükek, Sacide Pehlivan, Alpay Medetalibeyoglu
    Medicina.2025; 61(8): 1479.     CrossRef
  • Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective
    Inha Jung, Dae-Jeong Koo, Won-Young Lee
    Diabetes & Metabolism Journal.2024; 48(3): 327.     CrossRef
  • A Comprehensive Review of Pathophysiological Link Between Non-alcoholic Fatty Liver Disease, Insulin Resistance, and Metabolic Syndrome
    Eudith Januario, Aly Barakat, Abhivanditha Rajsundar, Zahra Fatima, Varda Nanda Palienkar, Arjun V Bullapur, Sunchandandeep Singh Brar, Punam Kharel, Mishal Mohammed Koyappathodi Machingal, Amena Backosh
    Cureus.2024;[Epub]     CrossRef

CPP : Cardiovascular Prevention and Pharmacotherapy
TOP